Janssen Cilag Ltd
Lobbying activity
The following activities occurred for this specific Subject Matter Area.
Meeting (2-5)
Four individual meetings on behalf of Janssen with four DPO's to discuss the IPHA pre budget submission 'IPHA Budget and Policy Perspective' with specific reference to an early access scheme for new and innovative medicines that would form part of any new agreement between the State and IPHA.
Informal communication (2-5)
Informal communication on one occasion with two DPO's on the IPHA pre budget submission and early access for new and innovative medicines.
Letter (2-5)
Two Letters to DPO's attaching the IPHA pre budget submission and referencing early access for new and innovative medicines.
Designated public officials lobbied
The following DPOs were lobbied during this return period on this specific Subject Matter Area. These DPOs were involved in at least one of the Lobbying Activities listed above, but not necessarily all of them. As returns are specific to a Subject Matter Area the above Lobbying Activities may be associated with multiple returns.